#Biofrontera #publishes #financial #results #quarter
WOBURN, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) — Biofrontera inc (Nasdaq: BRI) a biopharmaceutical company focused on the commercialization of dermatology products, announces that it will report financial results for the three and nine months ended September 30, 2022 ahead of the opening of U.S. financial markets on Monday, November 14, 2022 . The Company will host a conference call beginning at 11:00 am Eastern time same day to discuss these results, provide a business update and answer questions.
Information on conference calls and webcasts
| Incident: | Biofrontera Inc. Third Quarter 2022 Financial Results and Business Updates Conference Call |
| Date: | Monday 14 November 2022 |
| time: | 11:00 a.m. Eastern Time |
| telephone conference: | 1-877-877-1275 (US) 1-412-858-5202 (International) |
| web cast: | Live and 90-day replay webcasts are available here and at www.investors.biofrontera-us.com. |
About Biofrontera Inc.
Biofrontera Inc. is a US-based biopharmaceutical company that owns a portfolio of…
Read on GNW: Biofrontera Inc. publishes financial results for the third quarter
